Cell Reset: siRNA for Longevity
TRANSCRIPTIONAL DAMAGE
Diseases that shorten human lifespan are associated with cellular damage at the transcriptional level.
Junevity identifies genes that regulate cellular damage and health—transcription factors—and restores their expression to healthy levels.
BREAKTHROUGH SCIENCE
Junevity’s founders spent six years at UCSF and found transcription factors that can return aged human cells back to health, using machine learning and high-throughput screening.
JUNEVITY RESET DISCOVERY PLATFORM
The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors.
It builds on recent innovations in transcriptomics, AI and siRNA.
THERAPEUTICS DEVELOPMENT
Junevity is creating siRNA therapeutics to address diseases impacting billions of people worldwide, including in Obesity, Type 2 Diabetes, Frailty and more.
We imagine a world with longer, healthier lives for all.